Axa SA (NASDAQ:AXAHY) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Wednesday. The brokerage currently has a $33.00 target price on the financial services provider’s stock. Zacks Investment Research‘s price objective would indicate a potential upside of 12.28% from the company’s current price.

According to Zacks, “The AXA Group is an international group of insurance and related financial services companies. AXA’s insurance operations are diverse geographically, with activities in 50 countries, principally Western Europe, North America and the Asia/Pacific area. In the United States, AXA is represented through its 60% holding in The Equitable companies and its subsidiaries, Equitable Life, Alliance Capital management and Donaldson, Lufkin & Jenrette. “

Separately, ValuEngine raised Axa SA from a “buy” rating to a “strong-buy” rating in a research report on Thursday, July 27th.

Shares of Axa SA (NASDAQ:AXAHY) traded down 0.27% during midday trading on Wednesday, hitting $29.39. The stock had a trading volume of 81,635 shares. Axa SA has a 1-year low of $20.40 and a 1-year high of $30.26.

COPYRIGHT VIOLATION WARNING: “Axa SA (AXAHY) Rating Increased to Buy at Zacks Investment Research” was reported by American Banking News and is the property of of American Banking News. If you are reading this news story on another domain, it was illegally copied and republished in violation of United States and international trademark & copyright law. The correct version of this news story can be read at https://www.americanbankingnews.com/2017/09/13/axa-sa-axahy-rating-increased-to-buy-at-zacks-investment-research.html.

About Axa SA

AXA SA (AXA) is a France-based holding company engaged in the business of financial protection. The Company’s segments include Life & Savings, Property & Casualty, Asset Management , Banking and Holding companies. The Life & Savings segment’s products include a range of investment and savings products, as well as Protection and Health products.

Get a free copy of the Zacks research report on Axa SA (AXAHY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Axa SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axa SA and related companies with MarketBeat.com's FREE daily email newsletter.